InvestorsHub Logo
Followers 8
Posts 278
Boards Moderated 0
Alias Born 05/07/2012

Re: markjohn62 post# 141693

Tuesday, 06/12/2018 7:14:15 PM

Tuesday, June 12, 2018 7:14:15 PM

Post# of 330256
I don’t know the answer to your first two questions but I do know that the result of the first May meeting was to fast track the approval through a new pre-submission process at the fda. I am certainly not an expert on the nomenclature or the fda process but some others on the board may be. I just know our paperwork is sitting at the fda office and to my understanding it could only mean we are waiting for someone there to pick up the job and put it through. Again, I am not certain but this is my understanding. They were pulled from boots online bc I believe with the NHS you have to either be on the shelves or behind the counter. They chose behind the counter and the result is the current business with b brain which is better imo. With b Braun we have more resources to roll out to other countries etc. I believe the rest of Europe with follow suit soon. So if we cheer for anything on that front cheer for b Braun and the total pathways program. More people using that pain management process equals more actipathes. This is what I understand happened. Sucks though because we were number one online. I could be mistaken about the specifics but this is my understanding.